Polymer micelle medicine-carrying system

A drug-loading system and polymer technology, which can be used in anti-tumor drugs, drug combinations, pharmaceutical formulations, etc., can solve the problem of low active targeting, and achieve the effect of improving drug loading and physical stability.

Inactive Publication Date: 2004-09-01
涂家生 +1
View PDF0 Cites 28 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, active targeting is still low due to the absence of molecules with specific affinity for the target site on the surface

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polymer micelle medicine-carrying system
  • Polymer micelle medicine-carrying system
  • Polymer micelle medicine-carrying system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] This embodiment is the preparation of the methyl polyethylene glycol-polylactic acid block copolymer that prepares etoposide and the mensuration of molecular weight, CMC

[0029] Materials and Methods

[0030] D, L-lactide: purchased from Sigma, recrystallized three times with anhydrous ethyl acetate at 60°C before use, and at room temperature in P 2 o 5 Dry in medium vacuum for 24 hours. Etoposide, stannous octoate and methyl polyethylene glycol (molecular weight 2000) were purchased from Sigma.

[0031] 1. Synthesis of methyl polyethylene glycol-polylactic acid block copolymer:

[0032] A ring-opening polymerization method is adopted to prepare methyl polyethylene glycol-polylactic acid block copolymers with a mass ratio of 5 / 95, or 20 / 80, or 50 / 50, respectively. A) Weigh 0.5g of methyl polyethylene glycol and 9.5g of lactide to prepare 5 / 95 methyl polyethylene glycol-polylactic acid block copolymer; B) Weigh 2g of methyl polyethylene glycol and lactide Ester 8g pr...

Embodiment 2

[0047] Preparation and particle size determination of etoposide-methylpolyethylene glycol-polylactic acid block copolymer micelles

[0048] 1. Preparation of etoposide-methyl polyethylene glycol-polylactic acid block copolymer micelles

[0049] Weigh 50 mg of etoposide and 100 mg of methyl polyethylene glycol-polylactic acid block copolymer respectively into a flask, add 50 ml of acetonitrile, and stir until dissolved. Under continuous stirring, 25ml of water was slowly added dropwise, stirring was continued for 15 minutes, and 75ml of water was further added dropwise. Slowly evaporate acetonitrile (rotary evaporator) at 60°C under vacuum. After no obvious acetonitrile evaporates, increase the temperature and vacuum, and continue to evaporate to a sample volume of about 80ml. The sample volume is adjusted to 100ml with water. The product is sterilized by filtration with a 0.22mm microporous membrane.

[0050] 2. Particle size determination of etoposide-methyl polyethylene gl...

Embodiment 3

[0053] Preparation of RGD-stearic acid amide Preparation of stearic acid-N-succinimide: Take 0.02 mole of stearic acid and 0.02 mole of N-hydroxysuccinimide, and dissolve them in 20 ml of tetrahydrofuran at 0°C with constant stirring. 0.02 mol of dicyclohexylcarbodiimide was added and stirred overnight at room temperature. The solvent was removed by filtration, and the residue was washed with sodium bicarbonate and recrystallized from methanol. Preparation of dimethyl RGD: 500 mg of RGD (Arg-Gly-Asp tripeptide, Bachem) was dissolved in 20 ml of methanol and kept at 0°C. Add 2ml of thionyl(di)chloride and stir overnight at room temperature. Evaporate the solvent under reduced pressure to obtain dimethyl RGD.

[0054] The preparation of dimethyl RGD-stearic acid amide: get equimolar dimethyl RGD solution (dimethylformamide is solvent) and stearic acid N-succinimide solution (ethylene glycol dimethyl ether is solvent) and mix well, add an appropriate amount of triethylamine to...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention relates to a method for making medicinal preparation, in particular a polymer micelle drug loading system and preparation, wherein the micelle is methyl polyethylene glycol - polyester segmented copolymer micelle, characterized by that, the ratio of methyl polyethylene glycol and polyester is less than 50/50, and the advantages of the segmented copolymer micelle is low critical micelle concentration, high drug loading capacity and stabilized micelle.

Description

Technical field: [0001] The invention relates to a pharmaceutical preparation technology, in particular to a polymer micelle drug loading system and its preparation. Background technique: [0002] The biggest obstacle to the administration of poorly soluble drugs (especially injection administration) is low solubility, which makes it difficult to prepare suitable preparations. It is often necessary to adopt various methods to increase solubility, such as preparing the drug into a salt, adding a latent solvent, adding a co-solvent, and adding a surfactant to solubilize. Since salt formation often requires strong acid or strong alkali conditions, it is often not suitable for many drugs; there are few physiologically safe latent solvents, and the dosage is limited; the safety of co-solvents that increase drug solubility by forming complexes with drugs is not easy to guarantee; Relatively speaking, solubilization via surfactant micelles is often the first choice due to the avai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/34A61P35/00C08L101/06
Inventor 吴建梅
Owner 涂家生
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products